NuVasive Reports 4Q18 Revenue of $288.3MM, +6.3% vs. 4Q17

NuVasive reported 4Q18 revenue of USD $288.3MM, +6.3%. vs. 4Q17, with 2018 full-year revenue of $1,101.7MM, +7.3% vs. 2017. Against the backdrop of a stable U.S. spine market, the company provided 2019 guidance in the range of $1.14BB to $1.16BB.

Growth in the spine segment was driven by new product introductions such as TLIF and XLIF...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us